Prostate-cancer screening - What the U.S. Preventive Services Task Force left out

New England Journal of Medicine

Volumn 365, Issue 21, 2011, Pages 1949-1951

  Brett, Allan S ^a   Ablin, Richard J ^b  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

CANCER MORTALITY; CANCER PATIENT; CANCER SCREENING; HEALTH CARE ORGANIZATION; HEALTH CARE PRACTICE; HEALTH SERVICE; HUMAN; PRIORITY JOURNAL; PROSTATE CANCER; SHORT SURVEY; TUMOR BIOPSY; UNITED STATES; UNITED STATES PREVENTIVE SERVICE TASK FORCE;

EID: 81855227059     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp1112191     Document Type: Short Survey

References (5)

1. Screening for prostate cancer: draft recommendation statement. Rockville, MD: U.S. Preventive Services Task Force, October 7, 2011 (http://www. uspreventiveservicestaskforce.org/draftrec3.htm).
2. Prostate-specific antigen best practice statement: 2009 update. Linthicum, MD: American Urological Association, 2009 (http://www.auanet.org/ content/media/psa09.pdf).
3. Wolf AMD, Wender RC, Etzioni RB, et al. American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin 2010;60:70-98.
4. Thompson IM, Pauler DK, Goodman PJ, et al. Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter. N Engl J Med 2004;350:2239-46. [Erratum, N Engl J Med 2004;351:1470.]
5. Department of Health and Human Services. ASPE issue brief - overview of the uninsured in the United States: a summary of the 2011 current population survey. September 13, 2011 (http://aspe.hhs.gov/health/reports/2011/ CPSHealthIns2011/ib.pdf).